ZAMED TerraTrust’s Post

🌟 𝑮𝒐𝒐𝒅 𝑴𝒐𝒓𝒏𝒊𝒏𝒈 𝒘𝒊𝒕𝒉 𝒕𝒉𝒆 𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒆𝒆𝒌! 🌟   🏆Major achievements for MEDEA Biopharma and for the whole German Startup Ecosystem! MEDEA Biopharma was selected as one of the 16 winners at the StartupGermanySummit2024, proudly representing Rheinland-Pfalz. This recognition highlights the significance of our approach and the critical importance of tackling antibiotic resistance. https://bit.ly/3ZB3zSM Giorgi Khubua, Rüdiger Trojok   🏆 Zamann Pharma Support's development of Europe's first sustainable and biodegradable pregnancy test, under the brand Terra Trust, has been nominated for the prestigious DQS Sustainability Award 2024 in the "Sustainable Innovation" category. This nomination recognizes their commitment to environmental protection and sustainable innovation. The DQS Sustainability Awards honor companies pioneering sustainability efforts, acknowledging innovative approaches to environmental protection and social responsibility across industries. The nomination highlights the growing importance of sustainable solutions in all areas of life, including healthcare. https://bit.ly/3BonNVN Alireza Zarei   🚀 Quality standards for looking into the tumor genome - Personalized medicine with individually tailored therapies is becoming more and more a reality in cancer. This requires a precise look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out in Germany. The data is a prerequisite for integrating gene sequencing into routine care. The working group led by Professor Albrecht Stenzinger from the Medical Faculty of Universität Heidelberg was in charge of the project. https://shorturl.at/bDtf6   👉 Find all news and much more in our newslounge at BioRN-Website: https://bit.ly/3U771lw